DNMT3A co-mutation is required for FLT3-ITD as an adverse prognostic indicator in intermediate-risk cytogenetic group AML

Juan MaDepartment of Clinical Laboratory, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China;

http://orcid.org/0000-0003-0087-1204

Jennifer DunlapDepartment of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR, USA;

Aleksandra PaligaDepartment of Pathology, The Ottawa Hospital, Ottawa, Canada;

Elie TraerDivision of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA

Richard PressDepartment of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR, USA;

http://orcid.org/0000-0002-2103-5144

Lisong ShenDepartment of Clinical Laboratory, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China;

Guang FanDepartment of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR, USA; Correspondence[email protected]

show all

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Wei Xie, Philipp W. Raess, Jennifer Dunlap, Cristina Magallanes Hoyos, Hongmei Li, Peng Li, Ronan Swords, Susan B. Olson, Fei Yang, Tauangtham Anekpuritanang, Shimin Hu, Joanna Wiszniewska, Guang Fan, Richard D. Press & Stephen R. Moore. (2022) Adult acute myeloid leukemia patients with NUP98 rearrangement have frequent cryptic translocations and unfavorable outcome. Leukemia & Lymphoma 63:8, pages 1907-1916.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

DNMT3A co-mutation is required for FLT3-ITD as an adverse prognostic indicator in intermediate-risk cytogenetic group AML

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

DNMT3A co-mutation is required for FLT3-ITD as an adverse prognostic indicator in intermediate-risk cytogenetic group AML

Citations (1)

Read on this site (1)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date